Search
Menu
Home
HTB
2018
November
HTB
November 2018
Contents
Editorial
13 November 2018: vol 19 no 17: HIVR4P and Glasgow conferences: first reports
Conference reports
Glasgow HIV Congress (2018)
No additional neural tube defects with preconception dolutegravir: data from three birth outcome cohorts
Insufficient data on risk of neural tube defects with exposure to elvitegravir or bictegravir exposure during preconception or first trimester
Viral dynamics of dolutegravir-based dual versus triple ART
Ibalizumab: 48-week phase 3 results in 27 participants with MDR HIV
Fostemsavir: 48-week phase 3 results from BRIGHTE study
Dolutegravir non-inferior to low dose efavirenz in real-life African study conducted in Cameroon
3rd HIV Research for Prevention Conference (R4P2018)
How to evaluate PrEP and vaccines: urgency for next generation compounds
Dual bNAb maintains viral suppression for median 21 weeks off-ART
Cabotegravir levels can be detected several years: PK tail to be covered by oral PrEP
3D imaging show HIV infection might establish within hours
bNAbs for HIV prevention: extended-release VRC01, AMP study, 10E8 safety signal and pan-clade challenges
Why U=U does not cover breastfeeding
Antiretrovirals
FDA updates rilpivirine label for use during pregnancy
Treatment access
Activists demand $1 a day access to bedaquiline for MDR TB
Guidelines
EACS guidelines – version 9.1 update (2018)
Side effects
Cannabis-based products for medicinal use: Guidance to clinicians
PDFs
13 November 2018: vol 19 no 17
HTB RSS
Early access
Bipolar disorder in people living with HIV
1 November 2024
Mpox breakthrough cases after two doses of the MVA-BN vaccine
1 November 2024
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
1 November 2024
All early access reports
Current issues
November 2024
October 2024
September 2024
Back issues
Special report
HTB news: i-Base changes during 2024
1 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate